These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7324227)

  • 21. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of cardiac insufficiency: vasodilator agents].
    Delius W
    Fortschr Med; 1982 Nov; 100(42):1959-68. PubMed ID: 6759338
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neurohormonal mechanisms in cardiac insufficiency. Possible therapeutic implications].
    Iannetti MV; Vallebona A; Perocchio M
    Minerva Cardioangiol; 1993 Mar; 41(3):81-9. PubMed ID: 8510813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic monitoring and vasodilator therapy in acute left ventricular failure. Preliminary report on a new vasodilator, tolmesoxide.
    Mullie A; Lust P; Nievel J; Penninckx J; Vanhove L; Van Hoonacker G; Vendevelde K; Fenwick J; Coghill J
    Acta Anaesthesiol Belg; 1980; 31 Suppl():147-54. PubMed ID: 7457056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Protocol-guide in clinical experimentation on vasodilator agents in chronic cardiac failure].
    Binaghi G; Mancia G; Vidotto G; Mestroni L
    G Ital Cardiol; 1985 Jul; 15(7):700-4. PubMed ID: 4076704
    [No Abstract]   [Full Text] [Related]  

  • 29. [Heart failure: causes and therapy of unstableness].
    Opasich C; Sinagra G
    G Ital Cardiol; 1995 Nov; 25(11):1433-7. PubMed ID: 8682240
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure.
    Motro M; Freimark D; Feinberg MS; Wynne RD; King C; Schneeweiss A
    Int J Clin Pharmacol Res; 1993; 13(3):143-9. PubMed ID: 8225697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of nitrates in therapy of heart failure].
    Strasser RH
    Herz; 1996 Jun; 21 Suppl 1():35-7. PubMed ID: 8767923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of early and manifest heart failure with vasodilator agents].
    Just H; Drexler H; Meinertz T
    Verh Dtsch Ges Inn Med; 1985; 91():139-43. PubMed ID: 4090611
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs for chronic heart failure.
    Med Lett Drugs Ther; 1993 May; 35(896):40-2. PubMed ID: 8097552
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasodilators. A re-evaluation of their role in heart failure.
    Stevenson LW; Fonarow G
    Drugs; 1992 Jan; 43(1):15-36. PubMed ID: 1372857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of cardiac insufficiency with special reference to vasodilator agents].
    Burkart F
    Ther Umsch; 1981; 38 Suppl():40-4. PubMed ID: 7339915
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug regimens for congestive heart failure.
    Unverferth DV; Magorien RD; Leier CV
    Geriatrics; 1980 Jul; 35(7):26-33. PubMed ID: 7380254
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vasodilators. 2-Treatment of arterial hypertension, cardiac insufficiency and peripheral vascular diseases].
    Langlois S; Ogilvie RI
    Union Med Can; 1981 Oct; 110(10):850-6. PubMed ID: 7303307
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasodilator therapy in heart failure.
    Kubo SH
    J Heart Lung Transplant; 1994; 13(4):S122-5. PubMed ID: 7947868
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.